Business
Todos Medical Announces Preprint of Acute COVID-19 Paxlovid Rebound Rescued by Tollovid
Todos Medical Announces Preprint of Acute COVID-19 Paxlovid Rebound Rescued by Tollovid.
About this update from Todos Medical Ltd.
[{"type":"text","content":"\n New York, NY, and Tel Aviv, ISRAEL, Aug. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL Pharma Ltd. reported the preprint in ResearchGate of a case study entitled “Tollovid as a Rescue Agent for Paxlovid Rebound in Acute COVID-19” overseen by Dr. Lee Morgentaler in concert with Andrew A. Blumenthal, RN ADS of a patient with Post-Acute Sequelae of COVID (PASC, or “Long COVID”) who  experienced multiple reinfections with SARS-CoV-2 virus over 27 months and experienced full COVID symptom resolution with a 5-day course of Paxlovid® treatment following positive PCR after which the patient immediately experienced COVID rebound that was resolved following consumption of supplementation with 3CL protease inhibitor immune support dietary supplement Tollovid™. The pre-publication can be viewed at: https://www.researchgate.net/publication/362387662_Tollovid_as_Rescue_Agent_for_Paxlovid_Rebound_in_Acute_Covid-19 .  ABSTRACT The current COVID-19 outbreak caused by the novel SARS-CoV-2 virus continues to be a worldwide emergency. According to the CDC, the main form of treatment for mild to moderate COVID-19 is Paxlovid, an oral antiviral consisting of Nirmatrelvir and Ritonavir. However, patients have reported subsequent positive viral antigen and the recurrence of COVID-19 symptoms within 2 to 8 days of completing their recommended 5-day course of Paxlovid. Here we outline a case of SARS-CoV-2 re-infection in a Long COVID patient treated with Paxlovid. The subject reported rebound symptoms immediately after completing a 5-day course of Paxlovid. In this case study, we outline subsequent supplementation with Tollovid, a botanical 3CL protease inhibitor immune support supplement, resulting in resolution of acute COVID symptoms.  To purchase Tollovid please visit Amazon or www.MyTollovid.com. About Tollovid® and Tollovid Daily™ Tollovid and Tollovid Daily are oral dietary supplement products made from natural ingredients that help support and maintain healthy immune function and also have potent 3CL protease inhibition properties based upon in vitro functional assays that show ...